The Latest Breaking News from Pfizer

Shares of Novavax (NASDAQ: NVAX) fell 26.2% on Jul 14, after the European Medicines Agency's (TSE: EMA) Pharmacovigilance Risk Assessment Committee ("PRAC") updated the product label of Nuvaxovid, the company's COVID-19 vaccine, to include some potential side effects like severe aller

The BA.5 strain represented 65% of cases from July 3 to 9, according to data from the Centers of Disease Control and Prevention.

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

Pfizer and Moderna have refused to divulge details of how to make their cutting-edge COVID shots. Here's what two scientists — and longtime best friends — are doing about it.

The U.S. is getting another COVID-19 vaccine choice

For Australians over 30, a fourth COVID-19 vaccine jab is now available. In Israel, the first country in the world to embrace the second booster, the benefits for some people were dramatic.

Over the years, many have taken to search engine Google to find out exactly how to pronounce big name brands correctly.

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

BALTIMORE — If you’ve recently been infected with COVID-19 or know someone infected, and you probably do, you can probably blame BA.5, one of five subvariants of omicron and possibly the most transmissible yet.